call on doc glp-1 A nurse lost her eyesight while drugs. She said she did not know of the potential risk, which is listed on the packaging in Europe but not in the U.S Call-On-Doc (@callondoc) · Dallas, TX

doi.org/10.1097/MCO.0000000000000162 7 Wilding JPH, et al

Potential Benefits of CJC-1295 / Ipamorelin The synergy between CJC 1295 and Ipamorelin delivers benefits that can go beyond typical hormone optimization

Eur J Pharmacol 2019;864:172715.ArticlePubMed 108

AOD-9604 is the most targeted option for fat metabolism, specifically designed to stimulate lipolysis and inhibit fat cell formation without elevating IGF-1 or disrupting insulin sensitivity, making it a relevant choice given that perimenopausal women already face increased insulin resistance risk

Simultaneously, these drugs suppress glucagon secretion, which prevents the liver from releasing excess glucose into the bloodstream